tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Similar Stocks

Compare
514 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Fulcrum Therapeutics
$13.80
$635.35M
199.77%
8 Buy
1 Hold
1 Sell
Moderate Buy
Monopar Therapeutics Inc
$78.22
$504.13M
217.73%
12 Buy
0 Hold
0 Sell
Strong Buy
ADC Therapeutics
$4.01
$437.29M
88.29%
3 Buy
0 Hold
0 Sell
Strong Buy
Opthea Limited Sponsored ADR
$0.20
$477.76M
-3.01
-98.85%
0 Buy
0 Hold
0 Sell
Hold
Monte Rosa Therapeutics
$17.23
$1.11B
56.42
94.59%
4 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$84.51
$1.22B
443.72%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FULC
Fulcrum Therapeutics
12.80
8.84
223.23%
MNPR
Monopar Therapeutics Inc
77.05
51.67
203.59%
ADCT
ADC Therapeutics
4.18
2.29
121.16%
OPT
Opthea Limited Sponsored ADR
0.04
-3.21
-98.77%
GLUE
Monte Rosa Therapeutics
16.56
9.00
119.05%
INBX
Inhibrx Biosciences Inc
82.21
67.59
462.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts